CASI Pharmaceuticals
CASI
#10383
Rank
NZ$7.27 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-91.26%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.72. In 2024 the company made an earnings per share (EPS) of NZ-$4.37 a decrease over its 2023 EPS that were of NZ-$3.44.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.656.54%
2024NZ-$4.3726.73%
2023NZ-$3.44-32.89%
2022NZ-$5.1311.9%
2021NZ-$4.59-38.44%
2020NZ-$7.45-8.96%
2019NZ-$8.1950%
2018NZ-$5.4677.78%
2017NZ-$3.075.88%
2016NZ-$2.90-22.73%
2015NZ-$3.75-76.09%
2014NZ-$15.69318.18%
2013NZ-$3.75-71.79%
2012NZ-$13.3065.96%
2011NZ-$8.02-50%
2010NZ-$16.03-18.97%
2009NZ-$19.78-63.64%
2008NZ-$54.403.57%
2007NZ-$52.53-60.56%
2006NZ-$133.1997.22%
2005NZ-$67.53-2.7%
2004NZ-$69.41-45.59%
2003NZ-$127.56-61.8%
2002NZ-$333.92-25.52%
2001NZ-$448.35-21.38%
2000NZ-$570.2913.86%
1999NZ-$500.88149.53%
1998NZ-$200.7398.15%
1997NZ-$101.3010.2%
1996NZ-$91.92